Yearly hypertension screening in women with a history of pre-eclampsia: a cost-effectiveness analysis

被引:0
作者
J.T. Drost
J.P.C. Grutters
G.-J. van der Wilt
Y.T. van der Schouw
A.H.E.M. Maas
机构
[1] Isala Klinieken,Department of Cardiology
[2] Radboud University Medical Center,Department for Health Evidence
[3] University Medical Center Utrecht,Julius Center for Health Sciences and Primary Care
[4] Radboud University Medical Center,Department of Cardiology
来源
Netherlands Heart Journal | 2015年 / 23卷
关键词
Preeclampsia; Economic analysis; Cardiovascular screening;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:585 / 591
页数:6
相关论文
共 104 条
[1]  
Bellamy L(2007)Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis BMJ 335 974-7
[2]  
Casas JP(2003)Subclassification of preeclampsia Hypertens Pregnancy 22 143-8
[3]  
Hingorani AD(2008)Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses Am Heart J 156 918-30
[4]  
Williams DJ(2013)Cardiovascular disease risk in women with preeclampsia: systematic review and meta-analysis Eur J Epidemiol 28 1-19
[5]  
Von Dadelszen P(2011)Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update a guideline from the American Heart Association Circulation 123 1243-62
[6]  
Magee LA(2012)Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk Evaluation in FEMales study (PREVFEM) Eur J Prev Cardiol 19 1138-44
[7]  
Roberts JM(2014)Cost-effectiveness analysis of cardiovascular risk factor screening in women who experienced hypertensive pregnancy disorders at term. Pregnancy Hypertension 4 264-70
[8]  
McDonald SD(2013)Elevated blood pressure in pregnancy and subsequent chronic disease risk Circulation 127 681-90
[9]  
Malinowski A(2009)Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother Hypertension 53 944-51
[10]  
Zhou Q(2009)Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 b1665-83